TrialDiabetologia2016

Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes.

Elza Muscelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.